The estimated total economic cost in treating overactive bladder was 117 billion Korean Won (KRW, the currency of South Koea) in 2006 and 145 billion KRW in 2007.
The estimated total cost in treating stress urinary incontinence was 122 billion KRW in 2006 and 59 billion KRW in 2007.
urgency UI also results in substantial economic costs  OAB may severely impair quality of life, and its overall economic costs to society are substantial  Caring for incontinent patients in the long-term care setting was shown to result in substantial additional costs,  Overactive bladder (OAB) is a highly prevalent condition among older patients, and its presence is associated with the use of substantial healthcare resources and economic costs.
The 1995 societal cost of incontinence for individuals aged 65 years and older was $26.
3 billion, or $3565 per individual with urinary incontinence.
.
